Phase Ib/II Trial to Evaluate Safety and Efficacy of Oral Ixazomib in Combination With Sirolimus and Tacrolimus in the Prophylaxis of Chronic Graft-versus-host Disease.

Trial Profile

Phase Ib/II Trial to Evaluate Safety and Efficacy of Oral Ixazomib in Combination With Sirolimus and Tacrolimus in the Prophylaxis of Chronic Graft-versus-host Disease.

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 26 Jul 2017

At a glance

  • Drugs Ixazomib (Primary) ; Sirolimus (Primary) ; Tacrolimus (Primary)
  • Indications Graft-versus-host disease; Transplant rejection
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top